IUPAC Traditional

6-methyl-5-{5-[(1H-pyrazol-1-yl)methyl]-1,2,4-oxadiazol-3-yl}-2-(1H-pyrrole-2-carbonyl)-1,2,3,4-tetrahydro-2,7-naphthyridine

Compound number MolPort-005-020-036
Molecular weight 389.419
InChI key GSTSXKGGYJVIBM-UHFFFAOYSA-N
Molecular formula C20H19N7O2
DMSO Solubility soluble
SMILES Cc1ncc2CN(CCc2c1-c1noc(Cn2cccn2)n1)C(=O)c1ccc[nH]1
Best offer
$90.00
Including direct shipping

Pack size:
1 mg
Shipping to:
United States
Lead time:
21 business days
Adjust Requirements

ChemBridge Corporation

Direct S&H to USA
45.00 USD
Catalog
Screening compound
Ships out
21 business days
Purity
85%
Last updated
last week
In warehouse
1.00 mg
Salt: FREE

Supplier Catalogue Data

Pack size
Ships out
Price
Quantity
1 mg
January 9, 2023
45.00 USD
Simpler, smarter compound sourcing with Molport
  • Extensive vetted supplier network
  • Smart standardised systems and intelligent fulfilment
  • Experienced support and expert lab services
We supply companies including
Fraunhofer logo Domainex logo Reverie labs logo
Search and order chemical compounds instantly
View search options
Access and search our databases offline
Access databases

More Information

Compound identifiers

Compound number
MolPort-005-020-036

Names, Synonyms and 3rd Party Identifiers

Name
6-methyl-5-[5-(1H-pyrazol-1-ylmethyl)-1,2,4-oxadiazol-3-yl]-2-(1H-pyrrol-2-ylcarbonyl)-1,2,3,4-tetrahydro-2,7-naphthyridine

InChI

InChI
1/C20H19N7O2/c1-13-18(19-24-17(29-25-19)12-27-8-3-7-23-27)15-5-9-26(11-14(15)10-22-13)20(28)16-4-2-6-21-16/h2-4,6-8,10,21H,5,9,11-12H2,1H3
InChI key
GSTSXKGGYJVIBM-UHFFFAOYSA-N

Formula

Molecular formula
C20H19N7O2
Molecular weight
389.419

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback